About Newlimit
Newlimit is a biotechnology company focused on developing innovative solutions in the field of epigenetics. The company aims to harness the power of epigenetic reprogramming to create therapies that can address a variety of diseases, including cancer and autoimmune disorders. By leveraging advanced technologies and scientific research, Newlimit is committed to transforming the landscape of personalized medicine. The company collaborates with leading researchers and institutions to advance its mission and bring new treatments to market. Newlimit's approach is centered around understanding how epigenetic modifications can influence gene expression and ultimately impact health outcomes.
Company facts
- Industry
- Biotechnology
- Sub-industries
- Epigenetics, Therapeutics, Personalized Medicine, Genomics, Research and Development
- Location
- South San Francisco, United States
- Employees
- 11–50
- Revenue (USD)
- 1–5M
- Founded
- 2020
Products and services
Open Newlimit in GlobalDeal Is this your company? Update the details for free
More Biotechnology companies in United States
- Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. Founded in 1987 and… - Uw School Of Medicine And Public Health
The University of Wisconsin School of Medicine and Public Health (UWSMPH) is a leading institution dedicated to improving health through education, research, and service. It… - Bgi Genomics
BGI Genomics is a subsidiary of the BGI Group, one of the world’s largest genomics enterprises headquartered in Shenzhen, China. The company specializes in next‑generation… - Agilent Technologies
Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables… - Genentech
Genentech, a member of the Roche Group, is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious and… - Envigo
Envigo is a global provider of essential products and services for the research and development of new drugs and therapies. The company specializes in the breeding and supply of… - Illumina
Illumina, Inc. is a global leader in genomics, focused on developing innovative technologies for genetic analysis. Founded in 1998 and headquartered in San Diego, California… - Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics. Founded in 1952, the company develops, manufactures, and markets a broad range of… - Csl Behring
CSL Behring is a global biotechnology leader that develops and delivers innovative therapies for people with serious and rare diseases. The company specializes in the development… - Baxalta
Baxalta Incorporated was a global biopharmaceutical company that focused on developing and delivering innovative therapies for people with hemophilia, immune deficiencies, and… - Novonesis
Novonesis is a biotechnology company focused on developing innovative solutions for healthcare challenges. The company specializes in the research and development of biologics… - Celgene
Celgene Corporation, now a subsidiary of Bristol-Myers Squibb, is a biopharmaceutical company that discovers, develops, and commercializes innovative therapies for the treatment…